P3 Health Partners Inc (NASDAQ: PIII) is -6.63% lower on its value in year-to-date trading and has touched a low of $0.18 and a high of $1.35 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PIII stock was last observed hovering at around $0.23 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $0.21, the stock is -1.52% and -13.66% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.91 million and changing -7.49% at the moment leaves the stock -54.45% off its SMA200. PIII registered -83.97% loss for a year compared to 6-month loss of -63.67%. The firm has a 50-day simple moving average (SMA 50) of $0.24624 and a 200-day simple moving average (SMA200) of $0.465105.
The stock witnessed a -1.73% gain in the last 1 month and extending the period to 3 months gives it a -33.57%, and is -13.33% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.91% over the week and 14.80% over the month.
P3 Health Partners Inc (PIII) has around 400 employees, a market worth around $75.35M and $1.48B in sales. Profit margin for the company is -6.95%. Distance from 52-week low is 18.58% and -84.46% from its 52-week high. The company has generated returns on investments over the last 12 months (-38.77%).
The EPS is expected to grow by 11.08% this year
69.0 institutions hold shares in P3 Health Partners Inc (PIII), with institutional investors hold 32.53% of the company’s shares. The shares outstanding are 161.97M, and float is at 91.41M with Short Float at 0.89%. Institutions hold 24.99% of the Float.
The top institutional shareholder in the company is ALYESKA INVESTMENT GROUP, L.P. with over 15.95 million shares valued at $7.18 million. The investor’s holdings represent 13.4152 of the PIII Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 7.9 million shares valued at $3.56 million to account for 6.645 of the shares outstanding. The other top investors are AMERIPRISE FINANCIAL INC which holds 6.33 million shares representing 5.3228 and valued at over $2.85 million, while VANGUARD GROUP INC holds 1.5303 of the shares totaling 1.82 million with a market value of $0.82 million.
P3 Health Partners Inc (PIII) Insider Activity
The most recent transaction is an insider purchase by Chicago Pacific Founders UGP I, the company’s 10% Owner. SEC filings show that Chicago Pacific Founders UGP I bought 80,000 shares of the company’s common stock on Sep 12 ’24 at a price of $0.52 per share for a total of $41600.0. Following the purchase, the insider now owns 77.11 million shares.
P3 Health Partners Inc disclosed in a document filed with the SEC on Sep 13 ’24 that Chicago Pacific Founders UGP I (10% Owner) bought a total of 80,000 shares of the company’s common stock. The trade occurred on Sep 13 ’24 and was made at $0.50 per share for $39952.0. Following the transaction, the insider now directly holds 77.19 million shares of the PIII stock.
Still, SEC filings show that on Sep 11 ’24, Chicago Pacific Founders UGP I (10% Owner) acquired 80,000 shares at an average price of $0.56 for $44728.0. The insider now directly holds 77,025,438 shares of P3 Health Partners Inc (PIII).
